Lorinden A ointment 15g

Lorinden A Composition
active substances: flumethasoni pivalas; acidum salicyliccum;

1 g of ointment contains flumethasone pivalate – 0.2 mg, salicylic acid – 30.0 mg;

auxiliary substances: propylene glycol, lanolin, white soft paraffin.

Pharmacotherapeutic group
Corticosteroids in combination with an antiseptic for use in dermatology.

ATX code D07B B01.

Indication
Skin inflammation (without exudation), not complicated by bacterial infection, including allergic nature, accompanied by persistent itching and hyperkeratosis: seborrheic dermatitis, atopic dermatitis, nodular urticaria (papular urticaria), allergic contact dermatitis, erythema multiforme, red lupus, psoriasis, lichen planus.

Method of application and dosage
The drug is intended for local use. The ointment should be applied in a thin layer to the affected skin 1‒2 times a day. It is allowed to use the drug under an occlusive dressing. Treatment should not be carried out continuously for more than 2 weeks. Do not use on the skin of the face for more than 1 week. During the week, it is recommended to use no more than 1 tube.

With increased lichenization or excessive hyperkeratosis, it is allowed to use an occlusive bandage, which should be changed every 24 hours.